SNIPF yields 5405.41% · PFE yields 6.13%● Live data
📍 SNIPF pulled ahead of the other in Year 1
Combined, SNIPF + PFE cover 0 of 12 months — good coverage
Which stock is actually better after tax? Adjust your rate to find out.
What's the optimal mix of SNIPF + PFE for your $10,000?
Snipp Interactive Inc., a loyalty and promotions company, focuses on developing marketing engagement platforms in the United States, Canada, Ireland, and internationally. Its solutions include shopper marketing promotions, loyalty, rewards, rebates, and receipt processing. The company also engages in designing, executing, and promoting marketing programs. Snipp Interactive Inc. offers SnippCheck, a mobile receipt processing solution that allows brands to execute purchase-based promotions and loyalty programs; SnippWin, a promotion and sweepstakes platform provides various promotions from contests and simple sweepstakes to instant win programs and tiered, multi-level games; and SnippLoyalty, a solution that allows clients to deploy from simple punch-card programs to points-based loyalty programs with rewards stores. It also provides SnippRewards, a rewards platform that offers various rewards, including movie tickets, PayPal, and other money back mechanisms; and SnippInsights Data Analytics, a tool that collects and unifies data across all the programs that clients run on the snipp platform. In addition, the company offers SnippRebates, a SaaS platform that allows brands to set up and manage single-instance or cross-portfolio rebates; and SnippRx, a solution that allows medical practitioners to distribute incentives like coupons and pay-no-more cards direct to patients via text or email. It serves advertising agencies, brands and related marketing, and promotions agencies. Snipp Interactive Inc. was founded in 2007 and is headquartered in Vancouver, Canada.
Full SNIPF Calculator →Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under the Ibrance, Xtandi, Sutent, Inlyta, Retacrit, Lorbrena, and Braftovi brands; and sterile injectable and anti-infective medicines, and oral COVID-19 treatment under the Sulperazon, Medrol, Zavicefta, Zithromax, Vfend, Panzyga, and Paxlovid brands. The company also provides medicines and vaccines in various therapeutic areas, such as pneumococcal disease, meningococcal disease, tick-borne encephalitis, and COVID-19 under the Comirnaty/BNT162b2, Nimenrix, FSME/IMMUN-TicoVac, Trumenba, and the Prevnar family brands; biosimilars for chronic immune and inflammatory diseases under the Xeljanz, Enbrel, Inflectra, Eucrisa/Staquis, and Cibinqo brands; and amyloidosis, hemophilia, and endocrine diseases under the Vyndaqel/Vyndamax, BeneFIX, and Genotropin brands. In addition, the company is involved in the contract manufacturing business. It serves wholesalers, retailers, hospitals, clinics, government agencies, pharmacies, and individual provider offices, as well as disease control and prevention centers. The company has collaboration agreements with Bristol-Myers Squibb Company; Astellas Pharma US, Inc.; Myovant Sciences Ltd.; Akcea Therapeutics, Inc; Merck KGaA; Valneva SE; BioNTech SE; and Arvinas, Inc. Pfizer Inc. was founded in 1849 and is headquartered in New York, New York.
Full PFE Calculator →Save your analysis + weekly dividend insights. Free forever.
⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.